Clinical Utility of Serum Holotranscobalamin Measurements in Patients with First-Ever Ischemic Stroke
Background. Whether holotranscobalamin (holoTC) indicates B12 deficiency more sensitively than total vitamin B12 (B12) is unclear. This study is aimed at determining the impact of serum holoTC level as a risk factor for ischemic stroke and investigating its association with disease severity and shor...
Main Authors: | Oh Joo Kweon, Yong Kwan Lim, Mi-Kyung Lee, Hye Ryoun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2021/9914298 |
Similar Items
-
The importance of holotranscobalamin measurement
by: Čabarkapa Velibor, et al.
Published: (2007-01-01) -
Smoking is Not a Good Prognostic Factor following First-Ever Acute Ischemic Stroke
by: Ju-Hun Lee, et al.
Published: (2015-05-01) -
Assessing the measurement uncertainty of qualitative analysis in the clinical laboratory
by: Lim Yong Kwan, et al.
Published: (2020-02-01) -
Risk factors for pneumonia in patients who with first-ever ischemic stroke
by: Chih Hua Tseng, et al.
Published: (2015) -
Determinants of fatigue after first-ever ischemic stroke during acute phase.
by: Shan-Shan Wang, et al.
Published: (2014-01-01)